91 related articles for article (PubMed ID: 22033032)
1. New drugs for ALS: how do we get there?
Glass JD
Exp Neurol; 2012 Jan; 233(1):112-7. PubMed ID: 22033032
[No Abstract] [Full Text] [Related]
2. Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis.
Yoo YE; Ko CP
Exp Neurol; 2011 Sep; 231(1):147-59. PubMed ID: 21712032
[TBL] [Abstract][Full Text] [Related]
3. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
4. Intranasal delivery of insulin and a nitric oxide synthase inhibitor in an experimental model of amyotrophic lateral sclerosis.
Martinez JA; Francis GJ; Liu WQ; Pradzinsky N; Fine J; Wilson M; Hanson LR; Frey WH; Zochodne D; Gordon T; Toth C
Neuroscience; 2008 Dec; 157(4):908-25. PubMed ID: 18951954
[TBL] [Abstract][Full Text] [Related]
5. Targeting Macrophage for the Treatment of Amyotrophic Lateral Sclerosis.
Li L; Liu J; She H
CNS Neurol Disord Drug Targets; 2019; 18(5):366-371. PubMed ID: 30963986
[TBL] [Abstract][Full Text] [Related]
6. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
[TBL] [Abstract][Full Text] [Related]
7. Sterol regulatory element binding protein-1 (SREBP1) activation in motor neurons in excitotoxicity and amyotrophic lateral sclerosis (ALS): Indip, a potential therapeutic peptide.
Taghibiglou C; Lu J; Mackenzie IR; Wang YT; Cashman NR
Biochem Biophys Res Commun; 2011 Sep; 413(2):159-63. PubMed ID: 21871872
[TBL] [Abstract][Full Text] [Related]
8. Combined Treatment of an Amyotrophic Lateral Sclerosis Rat Model with Recombinant GOT1 and Oxaloacetic Acid: A Novel Neuroprotective Treatment.
Ruban A; Malina KC; Cooper I; Graubardt N; Babakin L; Jona G; Teichberg VI
Neurodegener Dis; 2015; 15(4):233-42. PubMed ID: 26113413
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid from amyotrophic lateral sclerosis patients causes fragmentation of the Golgi apparatus in the neonatal rat spinal cord.
Ramamohan PY; Gourie-Devi M; Nalini A; Shobha K; Ramamohan Y; Joshi P; Raju TR
Amyotroph Lateral Scler; 2007 Apr; 8(2):79-82. PubMed ID: 17453633
[TBL] [Abstract][Full Text] [Related]
10. A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1
Golko-Perez S; Amit T; Bar-Am O; Youdim MB; Weinreb O
Neurotox Res; 2017 Feb; 31(2):230-244. PubMed ID: 27826939
[TBL] [Abstract][Full Text] [Related]
11. Exposure to cerebrospinal fluid of sporadic amyotrophic lateral sclerosis patients alters Nav1.6 and Kv1.6 channel expression in rat spinal motor neurons.
Gunasekaran R; Narayani RS; Vijayalakshmi K; Alladi PA; Shobha K; Nalini A; Sathyaprabha TN; Raju TR
Brain Res; 2009 Feb; 1255():170-9. PubMed ID: 19109933
[TBL] [Abstract][Full Text] [Related]
12. Activation of mGlu3 metabotropic glutamate receptors enhances GDNF and GLT-1 formation in the spinal cord and rescues motor neurons in the SOD-1 mouse model of amyotrophic lateral sclerosis.
Battaglia G; Riozzi B; Bucci D; Di Menna L; Molinaro G; Pallottino S; Nicoletti F; Bruno V
Neurobiol Dis; 2015 Feb; 74():126-36. PubMed ID: 25434487
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
15. The effect of reserpine on transmission in the spinal cord.
Engberg I; Lundberg A; Ryall RW
Acta Physiol Scand; 1968; 72(1):115-22. PubMed ID: 4297708
[No Abstract] [Full Text] [Related]
16. DL-3-n-butylphthalide extends survival by attenuating glial activation in a mouse model of amyotrophic lateral sclerosis.
Feng X; Peng Y; Liu M; Cui L
Neuropharmacology; 2012 Feb; 62(2):1004-10. PubMed ID: 22056419
[TBL] [Abstract][Full Text] [Related]
17. The effect of bulbocapnine on spinal reflexes.
Willis WD; Willis JC; Pocock MA; Thompson WM
Exp Neurol; 1968 Mar; 20(3):469-80. PubMed ID: 5656856
[No Abstract] [Full Text] [Related]
18. Treatment with a coinducer of the heat shock response delays muscle denervation in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Kalmar B; Edet-Amana E; Greensmith L
Amyotroph Lateral Scler; 2012 Jun; 13(4):378-92. PubMed ID: 22591194
[TBL] [Abstract][Full Text] [Related]
19. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
Ng SK; Higashimori H; Tolman M; Yang Y
Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
[TBL] [Abstract][Full Text] [Related]
20. Lecithin is not effective in amyotrophic lateral sclerosis.
Kelemen J; Hedlund W; Murray-Douglas P; Munsat TL
Neurology; 1982 Mar; 32(3):315-6. PubMed ID: 7199648
[No Abstract] [Full Text] [Related]
[Next] [New Search]
